Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 13, 2019

SELL
$3.99 - $7.82 $470,045 - $921,242
-117,806 Closed
0 $0
Q3 2018

Nov 06, 2018

SELL
$3.52 - $5.55 $317,489 - $500,587
-90,196 Reduced 43.36%
117,806 $637,000
Q2 2018

Aug 10, 2018

BUY
$2.11 - $3.92 $10 - $19
5 Added 0.0%
208,002 $738,000
Q4 2017

Feb 06, 2018

BUY
$2.59 - $5.44 $538,712 - $1.13 Million
207,997
207,997 $549,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $443M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Ing Groep Nv Portfolio

Follow Ing Groep Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.